Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database
Wenchao Lu, Shihan Wang, Huilin Tang, et al.
European Psychiatry (2025) Vol. 68, Iss. 1
Open Access | Times Cited: 1
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study
Samantha B. Shapiro, Hui Yin, Oriana Hoi Yun Yu, et al.
BMJ (2025), pp. e080679-e080679
Closed Access | Times Cited: 1
Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study
Isabel Hurtado, Celia Robles, Salvador Peiró, et al.
Diabetologia (2024) Vol. 67, Iss. 11, pp. 2471-2480
Open Access | Times Cited: 8
Investigating the impact of intestinal glucagon-like peptide-1 on hypoglycemia in type 1 diabetes
Mahmoud Nassar, Angad Gill, Erlin Marte
World Journal of Diabetes (2025) Vol. 16, Iss. 3
Closed Access
The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Measures of Suicidality A Systematic Review
K.L. Valentino, Kayla M. Teopiz, William W. L. Cheung, et al.
Journal of Psychiatric Research (2025) Vol. 183, pp. 112-126
Open Access
The effect of GLP-1RAs on mental health and psychotropics-induced metabolic disorders: A systematic review
Sigrid Breit, Daniela Hubl
Psychoneuroendocrinology (2025), pp. 107415-107415
Closed Access
Use of glucagon-like peptide-1 receptor agonists in people with history of acute pancreatitis: TriNetX analysis
Mahmoud Nassar, Hazem Abosheaishaa, Anoop Misra, et al.
Diabetes & Metabolism (2025), pp. 101613-101613
Closed Access
Association of GLP‐1 Receptor Agonists With Risk of Suicidal Ideation and Behaviour: A Systematic Review and Meta‐Analysis
Ganesh Bushi, Mahalaqua Nazli Khatib, Shivam Rohilla, et al.
Diabetes/Metabolism Research and Reviews (2025) Vol. 41, Iss. 2
Open Access
Prevalence of Metabolic-Associated Steatotic Liver Disease in Patients with Type 2 Diabetes with and without HIV: Retrospective Multicenter Study
Hazem Abosheaishaa, Omar Nassar, Mostafa Alfishawy, et al.
(2025) Vol. 1, Iss. 2, pp. 8-12
Closed Access
Decreased Risk of Recurrent Acute Pancreatitis with Semaglutide and Tirzepatide in People with Type 2 Diabetes or Obesity with a History of Acute Pancreatitis: A Propensity Matched Global Federated TriNetX Database-Based Retrospective Cohort Study
Mahmoud Nassar, Omar Nassar, Hazem Abosheaishaa, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 9, pp. 103116-103116
Closed Access | Times Cited: 2
Comparative outcomes of systemic diseases in people with type 2 diabetes, or obesity alone treated with and without GLP-1 receptor agonists: a retrospective cohort study from the Global Collaborative Network
Mahmoud Nassar, Omar Nassar, Hazem Abosheaishaa, et al.
Journal of Endocrinological Investigation (2024)
Closed Access | Times Cited: 2
Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes – Case Presentations
Sujatha Seetharaman, Eda Cengiz
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 2
Assessing the benefit–risk profile of newer glucose‐lowering drugs: A systematic review and network meta‐analysis of randomized outcome trials
Huilin Tang, Bingyu Zhang, Yiwen Lu, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 1
Glucagon-like peptide-1 receptor agonists: Exploring the mechanisms from glycemic control to treatment of multisystemic diseases
Mo-Wei Kong, Yang Yu, Ying Wan, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 36, pp. 4036-4043
Closed Access
The Promise of Adjunct Medications in Improving Type 1 Diabetes Outcomes: Glucagon-like Peptide Receptor Agonists
Sujatha Seetharaman, Eda Cengiz
Journal of Diabetes Science and Technology (2024)
Closed Access
Page 1

Scroll to top